Klotho Neurosciences’ treatment of amyotrophic lateral sclerosis was granted FDA orphan designation, according to a post to the agency’s website.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KLTO:
- 3 Penny Stocks to Watch Now, 7/1/25
- Klotho Neurosciences Begins Manufacturing Gene Therapy for ALS
- Klotho Neurosciences moves forward with KLTO-202 manufacturing and development
- Klotho Neurosciences, ORCLS announce plan to study Blue Zone
- Klotho Neurosciences, SkyBell mutually terminate Share Exchange Agreement